Park Ha Biological Technology Co. Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Park Ha Biological Technology Co., Ltd. (BYAH) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Oct 2023Oct 2022Oct 2021
Operating Activities
Net Income0.480.850.19-0.48
Depreciation & Amortization0.020.020.030.04
Deferred Income Tax-0.02-0.030.000.00
Change in Working Capital0.25-0.911.17-0.05
Change in Accounts Receivable-0.14-0.34-0.09-0.02
Change in Inventory0.010.000.19-0.02
Change in Accounts Payable-0.180.510.060.06
Change in Other Working Capital0.560.05-0.240.00
Other Operating Activities0.230.050.040.00
Net Cash from Operating Activities0.960.131.44-0.50
Investing Activities
Capital Expenditures-0.09-0.02-0.01-0.01
Other Investing Activities-0.420.00-0.010.00
Net Cash from Investing Activities-0.511.02-1.55-0.01
Financing Activities
Debt Repayment-0.07-0.78-0.26-0.40
Common Stock Issued0.000.040.530.26
Other Financing Activities-0.890.000.000.00
Net Cash from Financing Activities-0.96-0.680.670.50
Summary
Effect of Forex Changes on Cash0.02-0.01-0.060.00
Net Change in Cash-0.490.470.50-0.01
Cash at Beginning of Period1.030.570.070.08
Cash at End of Period0.551.030.570.07
Free Cash Flow0.870.101.43-0.51
Supplemental Disclosures
Interest Paid0.000.000.000.00